UBS AM
SRRA

UBS AM’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

UBS AM’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,414
Closed -$573K – 2809
2022
Q2 		$573K Buy
+10,414
New +$546K ﹤0.01% 2257

Other funds holding SRRA

HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

UBS AM's SRRA Position: Q3 2022 in Review

UBS AM sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 10,414 shares — an estimated $573K sold.

UBS AM first reported a position in SRRA in Q2 2022 and held it in 1 quarter. The position peaked at $573K in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • UBS AM reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • UBS AM sold 10,414 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $573K.
  • UBS AM first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • UBS AM's Sierra Oncology, Inc. Common Stock position peaked at $573K in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on UBS AM's 13F filing for Q3 2022, filed 14 Nov 2022.